Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplasm, Residual
×
Gastrointestinal
×
Clear all
Filters
3
NCT04853017
2025-09-05
AMPLIFY-201
Elicio Therapeutics
Phase 1
Completed
25 enrolled
15 charts
NCT05219734
2024-03-12
MARIA
Invitae Corporation
Active not recruiting
400 enrolled